Nuzenio

Capivasertib

Capivasertib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Practical Implementation of Capivasertib-Abiraterone for PTEN-Deficient mHSPC - Zachary Klaassen, Brenda Martone, Kara Cossis & Christina Lee - UroTodayUroToday · Mon, 10 Aug 2026 20:18:54 GMTCAPItello-281 Trial Design and Efficacy Data in mHSPC - urologytimes.comurologytimes.com · Thu, 06 Aug 2026 12:08:03 GMTICR welcomes FDA approval of capivasertib for advanced prostate cancer - The Institute of Cancer Research (ICR)The Institute of Cancer Research (ICR) · Tue, 28 Jul 2026 10:33:25 GMT

Timeline

Mon, 10 Aug 2026 20:18:54 GMTPractical Implementation of Capivasertib-Abiraterone for PTEN-Deficient mHSPC - Zachary Klaassen, Brenda Martone, Kara Cossis & Christina Lee - UroToday
Thu, 06 Aug 2026 12:08:03 GMTCAPItello-281 Trial Design and Efficacy Data in mHSPC - urologytimes.com
Tue, 28 Jul 2026 10:33:25 GMTICR welcomes FDA approval of capivasertib for advanced prostate cancer - The Institute of Cancer Research (ICR)

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Capivasertib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.